case_images: PMC5829357_01
case_images: Trend of bilirubin (total and direct) during the course of hospitalization.
case_images: CRIHEP2018-9403934.001.jpg
case_images: PMC5829357_01_CRIHEP2018-9403934.001.jpg
case_images: fig1
case_images: Bilirubin gradually trended down to 7.3 mg/dl after days (Figure 1, trend of bilirubin).
case_images: Trend of AST/ALT/ALP during the course of hospitalization.
case_images: CRIHEP2018-9403934.002.jpg
case_images: PMC5829357_01_CRIHEP2018-9403934.002.jpg
case_images: fig2
case_images: Laboratory findings were significant for total bilirubin of 24.8 mg/dl with direct bilirubin of 18.8 mg/dl, AST of 76 IU/L (Figure 2), platelets of 28 K, and albumin of 2.7 gm/dl, and the rest of the laboratory findings were within the normal limits, including ALT, ALP (Figure 2), GGT, MCV, INR, and PT.
case_images: Liver biopsy showed focal steatosis, focal nonspecific chronic inflammation, and a nonspecific increase in the lipochrome pigment in hepatocytes.
case_images: CRIHEP2018-9403934.003.jpg
case_images: PMC5829357_01_CRIHEP2018-9403934.003.jpg
case_images: fig3
case_images: Liver biopsy (Figure 3) excluded hemochromatosis, dysplasia, or malignancy. It (Figure 3) reported focal steatosis, focal nonspecific chronic inflammation, and portal fibrosis and a nonspecific increase in the lipochrome pigment in hepatocytes.